Top in ID: New Paxlovid data; updates to flu, MMR, pneumococ

A recent study showed that Paxlovid was associated with a 46% reduction in severe COVID-19 or death among high-risk patients. It was the top story in infectious disease last week.

Related Keywords

United States , Israel , London , City Of , United Kingdom , Americans , , Advisory Committee On Immunization Practices , New Paxlovid , Healio Coverage , Immunization Practices , Adobe Stock ,